Risk Factors Associated with Intensive Care Admission in Children with Severe Acute Respiratory Syndrome Coronavirus 2-Related Multisystem Inflammatory Syndrome (MIS-C) in Latin America: A Multicenter Observational Study of the REKAMLATINA Network
Jaime Fernández-Sarmiento,Lorena Acevedo,Laura Fernanda Niño-Serna,Raquel Boza,Jimena García-Silva,Adriana Yock-Corrales,Marco A Yamazaki-Nakashimada,Enrique Faugier-Fuentes,Olguita Del Águila,German Camacho-Moreno,Dora Estripeaut,Iván F Gutiérrez,Kathia Luciani,Graciela Espada,Martha I Álvarez-Olmos,Paola Pérez-Camacho,Saulo Duarte-Passos,Maria C Cervi,Edwin M Cantillano,Beatriz A Llamas-Guillén,Patricia Saltigeral-Simental,Javier Criales,Enrique Chacon-Cruz,Miguel García-Domínguez,Karla L Borjas Aguilar,Daniel Jarovsky,Gabriela Ivankovich-Escoto,Adriana H Tremoulet,Rolando Ulloa-Gutierrez,Olguita del Águila,The REKAMLATINA-3 Study Group Investigators 32
DOI: https://doi.org/10.1177/08850666241233189
2024-02-29
Journal of Intensive Care Medicine
Abstract:Journal of Intensive Care Medicine, Ahead of Print. Background: Multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 varies widely in its presentation and severity, with low mortality in high-income countries. In this study in 16 Latin American countries, we sought to characterize patients with MIS-C in the pediatric intensive care unit (PICU) compared with those hospitalized on the general wards and analyze the factors associated with severity, outcomes, and treatment received. Study Design: An observational ambispective cohort study was conducted including children 1 month to 18 years old in 84 hospitals from the REKAMLATINA network from January 2020 to June 2022. Results: A total of 1239 children with MIS-C were included. The median age was 6.5 years (IQR 2.5-10.1). Eighty-four percent (1043/1239) were previously healthy. Forty-eight percent (590/1239) were admitted to the PICU. These patients had more myocardial dysfunction (20% vs 4%; P < 0.01) with no difference in the frequency of coronary abnormalities (P = 0.77) when compared to general ward subjects. Of the children in the PICU, 83.4% (494/589) required vasoactive drugs, and 43.4% (256/589) invasive mechanical ventilation, due to respiratory failure and pneumonia (57% vs 32%; P = 0.01). On multivariate analysis, the factors associated with the need for PICU transfer were age over 6 years (aOR 1.76 95% CI 1.25-2.49), shock (aOR 7.06 95% CI 5.14-9.80), seizures (aOR 2.44 95% CI 1.14-5.36), thrombocytopenia (aOR 2.43 95% CI 1.77-3.34), elevated C-reactive protein (aOR 1.89 95% CI 1.29-2.79), and chest x-ray abnormalities (aOR 2.29 95% CI 1.67-3.13). The overall mortality was 4.8%. Conclusions: Children with MIS-C who have the highest risk of being admitted to a PICU in Latin American countries are those over age six, with shock, seizures, a more robust inflammatory response, and chest x-ray abnormalities. The mortality rate is five times greater when compared with high-income countries, despite a high proportion of patients receiving adequate treatment.
critical care medicine